CTIM-11. SINGLE-CENTER, OFF-LABEL NEOADJUVANT PEMBROLIZUMAB FOR TREATMENT OF RECURRENT GBM AT UCLA

Authors: Shivani Baisiwala, Lu Sun, Benjamin Ellingson, Robert Prins, Phioanh L Nghiemphu, Timothy Cloughesy, Richard G Everson

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.243

Source: Full article